Cargando…
The hypolipidemic activity of Ayurvedic medicine, Arogyavardhini vati in Triton WR-1339-induced hyperlipidemic rats: A comparison with fenofibrate
BACKGROUND: Hyperlipidemia is a major risk factor of coronary heart disease. Currently available hypolipidemic drugs have been associated with number of side effects. Arogyavardhini vati, an Ayurvedic polyherbal formulation has been used for liver disorders. Therefore, present study was designed to...
Autores principales: | Kumar, Gajendra, Srivastava, Amita, Sharma, Surinder Kumar, Gupta, Yogendra Kumar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3821191/ https://www.ncbi.nlm.nih.gov/pubmed/24250146 http://dx.doi.org/10.4103/0975-9476.118707 |
Ejemplares similares
-
Safety and efficacy evaluation of Ayurvedic treatment (Arjuna powder and Arogyavardhini Vati) in dyslipidemia patients: A pilot prospective cohort clinical study
por: Kumar, Gajendra, et al.
Publicado: (2012) -
Synthesis of microwave-assisted carboxamides in Triton WR-1339-induced hyperlipidemic rats: possible hypolipidemic heterocyclic compounds
por: Al-Jammal, Basmah, et al.
Publicado: (2023) -
ACCELERATION OF HEPATIC CHOLESTEROL SYNTHESIS BY TRITON WR-1339
por: Frantz, Ivan D., et al.
Publicado: (1955) -
THE MECHANISM RESPONSIBLE FOR THE HYPERCHOLESTEREMIA INDUCED BY TRITON WR-1339
por: Friedman, Meyer, et al.
Publicado: (1953) -
Hypolipidemic action of chrysin on Triton WR-1339-induced hyperlipidemia in female C57BL/6 mice
por: Zarzecki, Micheli Stéfani, et al.
Publicado: (2014)